These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 26683212)

  • 1. In vitro model systems to investigate bile salt export pump (BSEP) activity and drug interactions: A review.
    Cheng Y; Woolf TF; Gan J; He K
    Chem Biol Interact; 2016 Aug; 255():23-30. PubMed ID: 26683212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of bile salt transport by drugs associated with liver injury in primary hepatocytes from human, monkey, dog, rat, and mouse.
    Zhang J; He K; Cai L; Chen YC; Yang Y; Shi Q; Woolf TF; Ge W; Guo L; Borlak J; Tong W
    Chem Biol Interact; 2016 Aug; 255():45-54. PubMed ID: 27000539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
    Morgan RE; Trauner M; van Staden CJ; Lee PH; Ramachandran B; Eschenberg M; Afshari CA; Qualls CW; Lightfoot-Dunn R; Hamadeh HK
    Toxicol Sci; 2010 Dec; 118(2):485-500. PubMed ID: 20829430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vesicle- and Hepatocyte-Based Assays for Identification of Drug Candidates Inhibiting BSEP Function.
    Van Brantegem P; Deferm N; Qi B; De Vocht T; Annaert P
    Methods Mol Biol; 2019; 1981():55-73. PubMed ID: 31016647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Morgan RE; van Staden CJ; Chen Y; Kalyanaraman N; Kalanzi J; Dunn RT; Afshari CA; Hamadeh HK
    Toxicol Sci; 2013 Nov; 136(1):216-41. PubMed ID: 23956101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Warner DJ; Chen H; Cantin LD; Kenna JG; Stahl S; Walker CL; Noeske T
    Drug Metab Dispos; 2012 Dec; 40(12):2332-41. PubMed ID: 22961681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of membrane cholesterol on BSEP/Bsep activity: species specificity studies for substrates and inhibitors.
    Kis E; Ioja E; Nagy T; Szente L; Herédi-Szabó K; Krajcsi P
    Drug Metab Dispos; 2009 Sep; 37(9):1878-86. PubMed ID: 19520776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BSEP inhibition: in vitro screens to assess cholestatic potential of drugs.
    Kis E; Ioja E; Rajnai Z; Jani M; Méhn D; Herédi-Szabó K; Krajcsi P
    Toxicol In Vitro; 2012 Dec; 26(8):1294-9. PubMed ID: 22120137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vitro Drug-Induced Liver Injury Prediction: Criteria Optimization of Efflux Transporter IC50 and Physicochemical Properties.
    Yucha RW; He K; Shi Q; Cai L; Nakashita Y; Xia CQ; Liao M
    Toxicol Sci; 2017 Jun; 157(2):487-499. PubMed ID: 28369588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced perturbations of the bile acid pool, cholestasis, and hepatotoxicity: mechanistic considerations beyond the direct inhibition of the bile salt export pump.
    Rodrigues AD; Lai Y; Cvijic ME; Elkin LL; Zvyaga T; Soars MG
    Drug Metab Dispos; 2014 Apr; 42(4):566-74. PubMed ID: 24115749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile salt excretion in skate liver is mediated by a functional analog of Bsep/Spgp, the bile salt export pump.
    Ballatori N; Rebbeor JF; Connolly GC; Seward DJ; Lenth BE; Henson JH; Sundaram P; Boyer JL
    Am J Physiol Gastrointest Liver Physiol; 2000 Jan; 278(1):G57-63. PubMed ID: 10644562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a mechanistic biokinetic model for hepatic bile acid handling to predict possible cholestatic effects of drugs.
    Notenboom S; Weigand KM; Proost JH; van Lipzig MMH; van de Steeg E; van den Broek PHH; Greupink R; Russel FGM; Groothuis GMM
    Eur J Pharm Sci; 2018 Mar; 115():175-184. PubMed ID: 29309877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biliary excretion of pravastatin and taurocholate in rats with bile salt export pump (Bsep) impairment.
    Cheng Y; Freeden C; Zhang Y; Abraham P; Shen H; Wescott D; Humphreys WG; Gan J; Lai Y
    Biopharm Drug Dispos; 2016 Jul; 37(5):276-86. PubMed ID: 27059119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravital Multiphoton Microscopy with Fluorescent Bile Salts in Rats as an In Vivo Biomarker for Hepatobiliary Transport Inhibition.
    Ryan J; Morgan RE; Chen Y; Volak LP; Dunn RT; Dunn KW
    Drug Metab Dispos; 2018 May; 46(5):704-718. PubMed ID: 29467212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation.
    Stieger B
    Handb Exp Pharmacol; 2011; (201):205-59. PubMed ID: 21103971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Two-Tiered In Vitro Approach to De-Risk Drug Candidates for Potential Bile Salt Export Pump Inhibition Liabilities in Drug Discovery.
    Hafey MJ; Houle R; Tanis KQ; Knemeyer I; Shang J; Chen Q; Baudy A; Monroe J; Sistare FD; Evers R
    Drug Metab Dispos; 2020 Nov; 48(11):1147-1160. PubMed ID: 32943412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 2 inositol 1,4,5-trisphosphate receptor modulates bile salt export pump activity in rat hepatocytes.
    Kruglov EA; Gautam S; Guerra MT; Nathanson MH
    Hepatology; 2011 Nov; 54(5):1790-9. PubMed ID: 21748767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basal efflux of bile acids contributes to drug-induced bile acid-dependent hepatocyte toxicity in rat sandwich-cultured hepatocytes.
    Susukida T; Sekine S; Ogimura E; Aoki S; Oizumi K; Horie T; Ito K
    Toxicol In Vitro; 2015 Oct; 29(7):1454-63. PubMed ID: 26055650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatobiliary transporters in drug-induced cholestasis: a perspective on the current identifying tools.
    de Lima Toccafondo Vieira M; Tagliati CA
    Expert Opin Drug Metab Toxicol; 2014 Apr; 10(4):581-97. PubMed ID: 24588537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: in vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat.
    Funk C; Ponelle C; Scheuermann G; Pantze M
    Mol Pharmacol; 2001 Mar; 59(3):627-35. PubMed ID: 11179459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.